Step Therapy's Balancing Act - Protecting Patients while Addressing High Drug Prices
- PMID: 35245014
- PMCID: PMC9067323
- DOI: 10.1056/NEJMp2117582
Step Therapy's Balancing Act - Protecting Patients while Addressing High Drug Prices
References
-
- Nayak RK, Pearson SD. The ethics of ‘fail first’: guidelines and practical scenarios for step therapy coverage policies. Health Aff (Millwood) 2014; 33: 1779–85. - PubMed
-
- Lenahan KL, Nichols DE, Gertler RM, Chambers JD. Variation in use and content of prescription drug step therapy protocols, within and across health plans. Health Aff (Millwood) 2021; 40: 1749–57. - PubMed
-
- Tharp L, Rothblatt Z. Do patients benefit from legislation regulating step therapy? Health Econ Policy Law 2021. April 12 (Epub ahead of print). - PubMed
-
- Safe Step Act of 2021, S. 464, 117th Cong. (2021–2022) (https://www.congress.gov/bill/117th-congress/senate-bill/464/text).
-
- Centers for Medicare and Medicaid Services. CMS empowers patients with more choices and takes action to lower drug prices. August 7, 2018. (https://www.cms.gov/newsroom/press-releases/cms-empowers-patients-more-c...).
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical